NO20072609L - Malonamid-derivater - Google Patents
Malonamid-derivaterInfo
- Publication number
- NO20072609L NO20072609L NO20072609A NO20072609A NO20072609L NO 20072609 L NO20072609 L NO 20072609L NO 20072609 A NO20072609 A NO 20072609A NO 20072609 A NO20072609 A NO 20072609A NO 20072609 L NO20072609 L NO 20072609L
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- halogen
- hydroxy
- substituted
- cycloalkyl
- Prior art date
Links
- WRIRWRKPLXCTFD-UHFFFAOYSA-N malonamide Chemical class NC(=O)CC(N)=O WRIRWRKPLXCTFD-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 10
- 229910052736 halogen Inorganic materials 0.000 abstract 7
- 150000002367 halogens Chemical group 0.000 abstract 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106395 | 2004-12-08 | ||
| EP05100816 | 2005-02-07 | ||
| PCT/EP2005/012834 WO2006061136A2 (fr) | 2004-12-08 | 2005-12-01 | Dérivés de malonamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072609L true NO20072609L (no) | 2007-06-19 |
Family
ID=36293585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072609A NO20072609L (no) | 2004-12-08 | 2007-05-24 | Malonamid-derivater |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7211573B2 (fr) |
| EP (1) | EP1828151B1 (fr) |
| JP (1) | JP4979590B2 (fr) |
| KR (1) | KR100890678B1 (fr) |
| CN (1) | CN101072760B (fr) |
| AR (1) | AR053987A1 (fr) |
| AT (1) | ATE504580T1 (fr) |
| AU (1) | AU2005313582B8 (fr) |
| BR (1) | BRPI0518615A2 (fr) |
| CA (1) | CA2589196A1 (fr) |
| DE (1) | DE602005027388D1 (fr) |
| DK (1) | DK1828151T3 (fr) |
| IL (1) | IL183293A0 (fr) |
| MX (1) | MX2007006504A (fr) |
| NO (1) | NO20072609L (fr) |
| NZ (1) | NZ555184A (fr) |
| PL (1) | PL1828151T3 (fr) |
| PT (1) | PT1828151E (fr) |
| RU (1) | RU2402538C2 (fr) |
| TW (1) | TWI349005B (fr) |
| WO (1) | WO2006061136A2 (fr) |
| ZA (1) | ZA200705018B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101516859B (zh) | 2006-09-20 | 2012-07-04 | 霍夫曼-拉罗奇有限公司 | 4-氧代-2,3,4,5-四氢-苯并[b][1,4]二氮杂*衍生物 |
| AU2008209861B2 (en) * | 2007-02-02 | 2012-08-09 | F. Hoffmann-La Roche Ag | 6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl derivatives |
| US8741889B2 (en) * | 2008-01-11 | 2014-06-03 | Hoffmann-La Roche Inc | Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor |
| MA33076B1 (fr) * | 2008-01-11 | 2012-03-01 | Hoffmann La Roche | Utilisation d'un inhibiteur de la gamma-secretase pour le traitement du cancer |
| EP3307721B1 (fr) * | 2015-06-11 | 2020-06-17 | H. Hoffnabb-La Roche Ag | Inhibiteurs de la voie de notch ciblée |
| CA3079786A1 (fr) | 2017-10-24 | 2019-05-02 | The Broad Institute, Inc. | Derives de 4h-pyrrolo[3,2-c]pyridin-4-one |
| EP3878836B1 (fr) | 2018-11-07 | 2025-07-23 | Chugai Seiyaku Kabushiki Kaisha | Procédé de production d'un dérivé de sérine o-substitué |
| US20240307362A1 (en) | 2019-04-24 | 2024-09-19 | Bayer Aktiengesellschaft | 4H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDS |
| EP3958865B1 (fr) | 2019-04-24 | 2025-12-10 | Bayer Aktiengesellschaft | Dérivés de 4h-pyrrolo[3,2-c]pyridin-4-one |
| GEP20247648B (en) | 2019-04-24 | 2024-07-25 | Bayer Ag | 4h-pyrrolo[3,2-c]pyridin-4-one compounds |
| CN112300019A (zh) * | 2019-07-31 | 2021-02-02 | 华东师范大学 | 一种邻乙酰氨基苯丁酸类化合物的制备方法 |
| WO2021198020A1 (fr) | 2020-03-31 | 2021-10-07 | Bayer Aktiengesellschaft | Dérivés de 3-(anilino)-2-[3-(3-alcoxy-pyridin-4-yl]-1,5,6,7-tétrahydro-4h-pyrrolo [3,2-c] pyridin-4-one en tant qu'inhibiteurs d'egfr pour le traitement du cancer |
| EP4305020A1 (fr) | 2021-03-09 | 2024-01-17 | Basf Se | Malonamides et leur utilisation comme herbicides |
| KR20240051210A (ko) * | 2021-08-25 | 2024-04-19 | 바스프 에스이 | 제초제 말론아미드 |
| KR20240054320A (ko) * | 2021-08-31 | 2024-04-25 | 바스프 에스이 | 축합된 고리계를 함유하는 제초성 말론아미드 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL72523A (en) * | 1983-08-12 | 1988-06-30 | Takeda Chemical Industries Ltd | 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them |
| JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
| WO1999067219A1 (fr) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Composes destines a inhiber la liberation et/ou la synthese du peptide beta-amyloide |
| GB0012671D0 (en) | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
| SI1511718T1 (sl) * | 2002-05-29 | 2009-08-31 | Hoffmann La Roche | Derivati n-acilaminobenzena kot selektivni inhibitorji monoaminske oksidaze b |
| TW200502221A (en) * | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| ATE402934T1 (de) | 2003-02-04 | 2008-08-15 | Hoffmann La Roche | Malonamidderivate als gamma-secretaseinhibitoren |
| US7060698B2 (en) | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
| AU2004270361B2 (en) | 2003-09-09 | 2009-06-25 | F. Hoffmann-La Roche Ag | Malonamide derivatives blocking the activity of gama-secretase |
| PT1673347E (pt) | 2003-10-06 | 2015-11-02 | Hoffmann La Roche | Derivados de dibenzo-azepina e benzo-diazepina substituídos, úteis como inibidores de secretase gama |
-
2005
- 2005-11-30 US US11/289,176 patent/US7211573B2/en not_active Expired - Fee Related
- 2005-12-01 KR KR1020077015604A patent/KR100890678B1/ko not_active Expired - Fee Related
- 2005-12-01 CA CA002589196A patent/CA2589196A1/fr not_active Abandoned
- 2005-12-01 DE DE602005027388T patent/DE602005027388D1/de not_active Expired - Lifetime
- 2005-12-01 EP EP05811672A patent/EP1828151B1/fr not_active Expired - Lifetime
- 2005-12-01 BR BRPI0518615-3A patent/BRPI0518615A2/pt not_active IP Right Cessation
- 2005-12-01 MX MX2007006504A patent/MX2007006504A/es active IP Right Grant
- 2005-12-01 PT PT05811672T patent/PT1828151E/pt unknown
- 2005-12-01 PL PL05811672T patent/PL1828151T3/pl unknown
- 2005-12-01 AT AT05811672T patent/ATE504580T1/de active
- 2005-12-01 DK DK05811672.4T patent/DK1828151T3/da active
- 2005-12-01 JP JP2007544779A patent/JP4979590B2/ja not_active Expired - Fee Related
- 2005-12-01 NZ NZ555184A patent/NZ555184A/en not_active IP Right Cessation
- 2005-12-01 CN CN2005800421635A patent/CN101072760B/zh not_active Expired - Fee Related
- 2005-12-01 WO PCT/EP2005/012834 patent/WO2006061136A2/fr not_active Ceased
- 2005-12-01 RU RU2007120211/04A patent/RU2402538C2/ru not_active IP Right Cessation
- 2005-12-01 AU AU2005313582A patent/AU2005313582B8/en not_active Ceased
- 2005-12-07 TW TW094143269A patent/TWI349005B/zh not_active IP Right Cessation
- 2005-12-07 AR ARP050105106A patent/AR053987A1/es unknown
-
2007
- 2007-05-17 IL IL183293A patent/IL183293A0/en unknown
- 2007-05-24 NO NO20072609A patent/NO20072609L/no not_active Application Discontinuation
- 2007-06-04 ZA ZA200705018A patent/ZA200705018B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ555184A (en) | 2010-01-29 |
| DK1828151T3 (da) | 2011-05-16 |
| AU2005313582A8 (en) | 2011-06-16 |
| CN101072760B (zh) | 2011-12-28 |
| AU2005313582A1 (en) | 2006-06-15 |
| ATE504580T1 (de) | 2011-04-15 |
| KR20070086979A (ko) | 2007-08-27 |
| AU2005313582B8 (en) | 2011-06-16 |
| WO2006061136A3 (fr) | 2006-08-03 |
| CA2589196A1 (fr) | 2006-06-15 |
| JP2008522994A (ja) | 2008-07-03 |
| EP1828151A2 (fr) | 2007-09-05 |
| BRPI0518615A2 (pt) | 2008-11-25 |
| US20060122168A1 (en) | 2006-06-08 |
| MX2007006504A (es) | 2007-06-22 |
| TWI349005B (en) | 2011-09-21 |
| PL1828151T3 (pl) | 2011-09-30 |
| IL183293A0 (en) | 2007-09-20 |
| JP4979590B2 (ja) | 2012-07-18 |
| CN101072760A (zh) | 2007-11-14 |
| HK1114840A1 (en) | 2008-11-14 |
| DE602005027388D1 (de) | 2011-05-19 |
| TW200626568A (en) | 2006-08-01 |
| WO2006061136A2 (fr) | 2006-06-15 |
| ZA200705018B (en) | 2010-04-28 |
| PT1828151E (pt) | 2011-06-16 |
| AU2005313582B2 (en) | 2011-06-02 |
| RU2007120211A (ru) | 2009-01-20 |
| EP1828151B1 (fr) | 2011-04-06 |
| RU2402538C2 (ru) | 2010-10-27 |
| AR053987A1 (es) | 2007-05-30 |
| KR100890678B1 (ko) | 2009-03-26 |
| US7211573B2 (en) | 2007-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20083917L (no) | Malonamidderivater som gammasekretaseinhibitorer | |
| TNSN06360A1 (fr) | 4-phenylamino-quinazoline-6-yl-amides | |
| JP2008526999A5 (fr) | ||
| AR037418A1 (es) | Derivados de benzotiazol | |
| NO20062689L (no) | Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer | |
| NO20073465L (no) | Benzotiazol-derivater | |
| SE0104334D0 (sv) | Therapeutic agents | |
| NO20062704L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| EA200601287A1 (ru) | Производные (3-оксо-3,4-дигидрохиноксалин-2-иламино) бензамида и родственные соединения в качестве ингибиторов гликогенфосфорилазы для лечения диабета и ожирения | |
| CY1106679T1 (el) | Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα | |
| NO20062370L (no) | Amidderivater | |
| TW200626568A (en) | Malonamide derivatives | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| NO20053748L (no) | Pyrrolopyridazinderivater. | |
| PE20070115A1 (es) | Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas | |
| DE60236719D1 (de) | Purinderivate als antagonisten an purinergen rezeptoren | |
| AR041298A1 (es) | Derivados de pirrolidona como inhibidores de maob | |
| EA200300071A1 (ru) | Терапевтический препарат для лечения невроза страха (тревоги) или депрессии и производные пиперазина | |
| JP2005538111A5 (fr) | ||
| TW201111375A (en) | N-substituted cyclic amino derivative | |
| WO2007039781A3 (fr) | Nouveaux composes | |
| CA2592345A1 (fr) | Derives de piperidine et d'azetidine en tant qu'inhibiteurs de glyt1 | |
| MX2008008694A (es) | Compuestos conjugados de amina terapeutica-arilsulfonamida. | |
| RU2007128080A (ru) | Производные пирролидиния в качестве мускариновых рецепторов мз | |
| NO20070972L (no) | Benzyloksyderivater som MAOB-inhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |